Immunohistochemical localization of CD31, NOTCH1 and JAGGED1 proteins in experimentally induced polycystic ovaries of immature rats

Acta Histochemica

Volumn 113, Issue 3, 2011, Pages 262-269

  Skrtic, Anita ^a   Sokolic, Lea ^a   Borovecki, Ana ^a   Rosa, Jagoda ^b   Fenzl, Vanja ^a  

^a University of Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

CD31; Hyperandrogenemia; JAGGED1; NOTCH1; Ovary; Rats

Indexed keywords

CASTOR OIL; CD31 ANTIGEN; JAGGED1; NOTCH1 RECEPTOR; PROGESTERONE; TESTOSTERONE; TESTOSTERONE ENANTATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMATURITY; IMMUNOHISTOCHEMISTRY; NONHUMAN; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; PROGESTERONE BLOOD LEVEL; PROTEIN LOCALIZATION; RAT; TESTOSTERONE BLOOD LEVEL; WEIGHT GAIN;

ANIMALS; ANTIGENS, CD31; CALCIUM-BINDING PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; OVARY; POLYCYSTIC OVARY SYNDROME; RATS; RATS, WISTAR; RECEPTOR, NOTCH1;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 79952008208     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2009.10.008     Document Type: Article

References (35)

1. Aherne SA Polycystic ovary syndrome. Nurs Stand 2004, 18:40-44.
2. Allon MA, Leach RE, Dunbar J, Diamond MP. Effects of chronic hyperandrogenism and/or administered central nervous system insulin on ovarian manifestation and gonadotropin and steroid secretion. Fertil Steril 2005, 83(Suppl 1):1319-1326.
3. Anderson E, Lee GY. The polycystic ovarian (PCOD) condition: apoptosis and epithelization of the ovarian antral follicles are aspects of cystogenesis the dehydroepiandrosterone (DHEA)-treated rat model. Tissue Cell 1997, 29:171-189.
4. Apter D, Vihko R. Endocrine determinants of fertility: serum androgen concentrations during follow-up of adolescents into the third decade of life. J Clin Endocrinol Metab 1990, 71:970-974.
5. Baravalle C, Salvetti NR, Mira GA, Pezzone N, Ortega HH Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat. Arch Med Res 2006, 37:830-839.
6. Beloosesky R, Gold R, Almog B, Sasson R, Dantes A, Land-Bracha A, et al. Induction of polycystic ovary by testosterone in immature female rats: modulation of apoptosis and attenuation of glucose/insulin ratio. Int J Mol Med 2004, 14:207-215.
7. Ben-Ze'ev A, Amsterdam A In vitro regulation of granulosa cell differentiation. J Biol Chem 1987, 262:5366-5376.
8. Day JR, Morales TH, Lu JK Male stimulation of luteinizing hormone surge, progesterone secretion and ovulation in spontaneously persistent estrous, aging rats. Biol Reprod 1988, 38:1019-1026.
9. Dunaif A, Thomas A Current concepts in the polycystic ovary syndrome. Annu Rev Med 2001, 52:401-419.
10. Dunaif A Insulin resistance and the polycystic ovary syndrome mechanism and implications for pathogenesis. Endocr Rev 1997, 18:774-800.
11. Foecking EM, Levine JE Effects of experimental hyperandrogenemia on the female rat reproductive axis: suppression of progesterone-receptor messenger RNA expression in the brain and blockade of luteinizing hormone surges. Gend Med 2005, 2:155-165.
12. Franks S, Stark J, Hardy K Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 2008, 14:367-378.
13. Henmi H, Endo T, Nagasawa K, Hayashi T, Chida M, Akutagawa N, et al. Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats. Biol Reprod 2001, 64:157-162.
14. Hrabe de Angelis M, McIntyre J, Gossler A Maintenance of somite borders in mice requires the Delta homologue Dll1. Nature 1997, 386:717-721.
15. Iso T, Hamamori Y, Kedes L Notch signaling in vascular development. Arterioscler Thromb Vasc Biol 2003, 23:543-553.
16. Isobe N, Kitabayashi M, Yoshimura Y Microvascular distribution and vascular endothelial growth factor expression in bovine cystic follicles. Domest Anim Endocrinol 2005, 29:634-645.
17. Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 2000, 14:1343-1352.
18. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009, 16:3-11.
19. Lee MT, Anderson E, Lee GY Changes in ovarian morphology and serum hormones in the rat after treatment with dehydroepiandrosterone. Anat Rec 1991, 231:185-192.
20. Legro RS Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab 2002, (Suppl 5):1367-1378.
21. Manneras L, Cajander S, Holmang A, Seleskovic Z, Lystig T, Lonn M, et al. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 2007, 148:3781-3791.
22. Mathews D, Andrews WW, Parker R, Ojeda SR A role for aromatizable androgens in female rat puberty. Biol Reprod 1987, 36:836-843.
23. Perello M, Castrogiovanni D, Moreno G, Gaillard RC, Spinedi E Neonatal hypothalamic androgenization in the female rat induces changes in peripheral insulin sensitivity and adiposity function at adulthood. Neuro Endocrinol Lett 2003, 24:241-248.
24. Ruiz A, Aguilar R, Tébar AM, Gaytán F, Sánchez-Criado JE RU486-treated rats show endocrine and morphological responses to therapies analogous to responses of women with polycystic ovary syndrome treated with similar therapies. Biol Reprod 1996, 55:1284-1291.
25. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19-25.
26. Singh KB Persistent estrus rat models of polycystic ovary disease: an update. Fertil Steril 2005, 84(Suppl 2):1228-1234.
27. Stener-Victorin E, Ploj K, Larsson BM, Holmang A Rats with steroid induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity. Reprod Biol Endocrinol 2005, 3:44.
28. Tamura N, Kurabayashi T, Nagata H, Matsushita H, Yahata T, Tanaka K Effects of testosterone on cancellous bone, marrow adipocytes, and ovarian phenotype in a young female rat model of polycystic ovary syndrome. Fertil Steril 2005, 84(Suppl 2):1277-1284.
29. Trombly DJ, Woodruff TK, Mayo KE Suppression of notch signaling in the neonatal mouse ovary decreases primordial follicle formation. Endocrinology 2008, 150:1014-1024.
30. Tsilchorozidou T, Overton C, Conway GS The pathophysiology of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2004, 60:1-17.
31. Urbanek M, Woodroffe A, Ewens KG, Diamanti-Kandarakis E, Legro RS, Strauss JF, et al. Candidate gene region for polycystic ovary syndrome (PCOS) on chromosome 19p13.2. J Clin Endocrinol Metab 2005, 90:6623-6629.
32. Uyttendaele H, Ho J, Rossant J, Kitajewski J Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc Natl Acad Sci USA 2001, 98:5643-5648.
33. Vorontchikhina MA, Zimmermann RC, Shawber CJ, Tang H, Kitajewski J Unique patterns of Notch1, Notch4 and Jagged1 expression in ovarian vessels during folliculogenesis and corpus luteum formation. Gene Expr Patterns 2005, 5:701-709.
34. Weinstein BM, Lawson ND Arteries, veins, notch, and VEGF. Cold Spring Harb Symp Quant Biol 2002, 67:155-162.
35. Xue Y, Gao X, Lindsell CE, Norton CR, Chang B, Hicks C, et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 1999, 8:723-730.